Company / Working Capital
Omnicell Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$203.5M
FY2025
5-year range
-$95.5M / $559.8M
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
#110 of 160
Health Care
What the data says
At $203M, Omnicell's working capital ranks #110 of 160 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from -$95M in FY2021 to $560M in FY2023.
Based on SEC 10-K filings.
$203M in FY2025 with a 5-year CAGR of -18.1%.
Declined from $560M to $203M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -23.4%
- 5-Year CAGR
- -18.1%
- 10-Year CAGR
- -
Sector benchmark
#110 of 160 in Health CareTop 69% of 160This company $203.5M Sector average $757.1M
▼
-73.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -18.1%, indicating a declining trend.
- In FY2025, working capital decreased 7.4% year-over-year.
- Ranks #110 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $203.5M | -7.4% |
| FY2024 | $219.8M | -60.7% |
| FY2023 | $559.8M | +23.5% |
| FY2022 | $453.4M | +574.9% |
| FY2021 | -$95.5M | -117.3% |
| FY2020 | $553.0M | +124.6% |
| FY2019 | $246.2M | +27.9% |
| FY2018 | $192.6M | +30.9% |
| FY2017 | $147.1M | +9.3% |
| FY2016 | $134.5M | -3.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026